Related references
Note: Only part of the references are listed.Measuring Demyelination and Remyelination in Acute Multiple Sclerosis Lesion Voxels
Paul S. Giacomini et al.
ARCHIVES OF NEUROLOGY (2009)
MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study
J. Bellmann-Strobl et al.
EUROPEAN RADIOLOGY (2009)
A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio
Michael Dwyer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference
Stephen M. Smith et al.
NEUROIMAGE (2009)
Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions
Jacqueline T. Chen et al.
ANNALS OF NEUROLOGY (2008)
Magnetization Transfer Ratio in Gray Matter A Potential Surrogate Marker for Progression in Early Primary Progressive Multiple Sclerosis
Zhaleh Khaleeli et al.
ARCHIVES OF NEUROLOGY (2008)
Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion
J. T. Chen et al.
NEUROIMAGE (2007)
Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease
H. Vrenken et al.
MULTIPLE SCLEROSIS (2007)
Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
Robert Zivadinov
NEUROLOGY (2007)
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
D. H. Miller et al.
NEUROLOGY (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Comparative analysis of neurotrophin receptors and ligands in vertebrate neurons: Tools for evolutionary stability or changes in neural circuits?
Christopher S. von Bartheld et al.
BRAIN BEHAVIOR AND EVOLUTION (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage
W Brück
JOURNAL OF NEUROLOGY (2005)
Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients
JT Chen et al.
NEUROIMAGE (2005)
Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis
MSA Deloire et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis
CM Dalton et al.
JOURNAL OF NEUROLOGY (2004)
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain
K Schmierer et al.
ANNALS OF NEUROLOGY (2004)
Short-term brain atrophy changes in relapsing-remitting multiple sclerosis
R Zivadinov et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Remyelinated lesions in multiple sclerosis -: Magnetic resonance image appearance
F Barkhof et al.
ARCHIVES OF NEUROLOGY (2003)
A controlled trial of natalizumab for relapsing multiple sclerosis.
DH Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS
R Zivadinov et al.
NEUROLOGY (2001)
In vivo evaluation of remyelination in rat brain by magnetization transfer imaging
MSA Deloire-Grassin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Share Paper
